clove and Whooping-Cough

clove has been researched along with Whooping-Cough* in 2 studies

Other Studies

2 other study(ies) available for clove and Whooping-Cough

ArticleYear
Leveraging serology to titrate immunisation programme functionality for diphtheria in Madagascar.
    Epidemiology and infection, 2022, 01-13, Volume: 150

    Diphtheria is a potentially devastating disease whose epidemiology remains poorly described in many settings, including Madagascar. Diphtheria vaccination is delivered in combination with pertussis and tetanus antigens and coverage of this vaccine is often used as a core measure of health system functioning. However, coverage is challenging to estimate due to the difficulty in translating numbers of doses delivered into numbers of children effectively immunised. Serology provides an alternative lens onto immunisation, but is complicated by challenges in discriminating between natural and vaccine-derived seropositivity. Here, we leverage known features of the serological profile of diphtheria to bound expectations for vaccine coverage for diphtheria, and further refine these using serology for pertussis. We measured diphtheria antibody titres in 185 children aged 6-11 months and 362 children aged 8-15 years and analysed them with pertussis antibody titres previously measured for each individual. Levels of diphtheria seronegativity varied among age groups (18.9% of children aged 6-11 months old and 11.3% of children aged 8-15 years old were seronegative) and also among the districts. We also find surprisingly elevated levels of individuals seropositive to diphtheria but not pertussis in the 6-11 month old age group suggesting that vaccination coverage or efficacy of the pertussis component of the DTP vaccine remains low or that natural infection of diphtheria may be playing a significant role in seropositivity in Madagascar.

    Topics: Adolescent; Antibodies, Bacterial; Bordetella pertussis; Child; Corynebacterium diphtheriae; Diphtheria; Diphtheria-Tetanus-Pertussis Vaccine; Female; Humans; Immunization Programs; Immunoglobulin G; Infant; Madagascar; Male; Seroepidemiologic Studies; Vaccination Coverage; Whooping Cough

2022
Seroprevalence of pertussis in Madagascar and implications for vaccination.
    Epidemiology and infection, 2020, 11-16, Volume: 148

    Pertussis is a highly contagious infectious disease and remains an important cause of mortality and morbidity worldwide. Over the last decade, vaccination has greatly reduced the burden of pertussis. Yet, uncertainty in individual vaccination coverage and ineffective case surveillance systems make it difficult to estimate burden and the related quantity of population-level susceptibility, which determines population risk. These issues are more pronounced in low-income settings where coverage is often overestimated, and case numbers are under-reported. Serological data provide a direct characterisation of the landscape of susceptibility to infection; and can be combined with vaccination coverage and basic theory to estimate rates of exposure to natural infection. Here, we analysed cross-sectional data on seropositivity against pertussis to identify spatial and age patterns of susceptibility in children in Madagascar. A large proportion of individuals surveyed were seronegative; however, there were patterns suggestive of natural infection in all the regions analysed. Improvements in vaccination coverage are needed to help prevent additional burden of pertussis in the country.

    Topics: Adolescent; Child; Child, Preschool; Cross-Sectional Studies; Humans; Infant; Madagascar; Pertussis Vaccine; Seroepidemiologic Studies; Time Factors; Vaccination; Whooping Cough

2020